the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers
Official Title A Phase 1a/1b Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers
Principal Investigator Luke, Jason
Brief Summary This is a phase 1a/b single-arm, open-label study to evaluate safety, tolerability, PK, and clinical benefit of FPA008 in combination with nivolumab in patients with selected advanced cancers.
Gender All
Ages 18 Years
Enrollment 280
Accepts Healthy Volunteers No
Lead Sponsor Five Prime Therapeutics, Inc.Industry
Collaborator Bristol-Myers SquibbIndustry
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name Michael S Gordon, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Advanced Solid Tumors, Including But Not Limited to Lung Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI